ImmunoACT - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2018, ImmunoACT operates in Health Tech offering gene-modified cell therapies, specifically CAR-T cell therapy for treating certain B-cell malignancies. The company was spun out from IIT-Bo...
Funding stage:
Corporate Round
Last funding:
30/05/2023
Total funding:
$17.18 Mn+
Revenue:
Investors
Employee count:
192
Last 90d
192
Last 90d
Web traffic:
3.51K
3.51K
Last 30d
Last 30d
Glassdoor Rating:
ImmunoACT: Funding Highlights
Funding highlights of ImmunoACT and a snapshot of its key metrics.
Total Funding$17.18 Mn+
Total Round(s)2
Funding Rounds
FAQs on Funding of ImmunoACT
Health Tech Funded ImmunoACT has raised a total funding of $17.18 million as of 31 May 2023 across 2 rounds. Find the details around funding rounds, participating investors, and other insights of ImmunoACT here...
ImmunoACT has raised a total of $17.18 million across 2 funding rounds and the last round was raised on 31 May 2023.
ImmunoACT's key investors include Laurus Labs.
ImmunoACT's last known valuation was $99.73 million as of 31 May 2023.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links